US government will fund 'at risk' manufacturing of lead vaccine candidates, with Trump promising US will get priority. But skeptics say year-end timeline is unrealistic.
President Trump has unveiled Operation Warp Speed, putting an ex-pharma leader and an army general in charge of developing and delivering a COVID-19 vaccine for the US by the end of 2020.
Former GlaxoSmithKline PLC executive Moncef Slaoui will be the project’s chief scientist, and will work alongside General Gustave Perna,...
Four Chinese companies have won approvals in China, the first anywhere, for novel drugs for diffuse large B-cell lymphoma, certain types of non-small cell lung cancer and influenza A.
IGI CEO Cyril Konto said in an interview that his company picked AbbVie for its agility, drug development acumen and expertise in areas like intellectual property and legal affairs.
CEO Rob Davis said the company is in pursuit of more deals as it looks to close the revenue gap looming from the loss of Keytruda in 2028.
